1. Home
  2. AVTX
  3. AVTX News

Latest Avalo Therapeutics Inc. (AVTX) News on December 24, 2024

Avalo Therapeutics initiated with a Buy at BTIG
AVTX

TipRanks

4 days ago

Avalo Therapeutics initiated with a Buy at BTIG

Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants
AVTX

GlobeNewswire

a month ago

Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants

Avalo Therapeutics to Present at Upcoming Investor Conferences
AVTX

GlobeNewswire

a month ago

Avalo Therapeutics to Present at Upcoming Investor Conferences

Avalo Reports Third Quarter 2024 Financial Results and Recent Business Updates
AVTX

GlobeNewswire

2 months ago

Avalo Reports Third Quarter 2024 Financial Results and Recent Business Updates

Avalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa
AVTX

GlobeNewswire

3 months ago

Avalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa

Avalo Announces Participation in September Investor Conferences
AVTX

GlobeNewswire

4 months ago

Avalo Announces Participation in September Investor Conferences

Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates
AVTX

GlobeNewswire

4 months ago

Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates

Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer
AVTX

GlobeNewswire

5 months ago

Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer

Avalo Therapeutics Announces Active IND for AVTX-009, an anti-IL-1β mAb, to Treat Hidradenitis Suppurativa
AVTX

GlobeNewswire

6 months ago

Avalo Therapeutics Announces Active IND for AVTX-009, an anti-IL-1β mAb, to Treat Hidradenitis Suppurativa

Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer
AVTX

GlobeNewswire

6 months ago

Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer

Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit
AVTX

GlobeNewswire

6 months ago

Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit

Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates
AVTX

GlobeNewswire

7 months ago

Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates

Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
AVTX

GlobeNewswire

9 months ago

Avalo Therapeutics Appoints Biotech Leaders to Board of Directors

Avalo Reports 2023 Financial Results and Provides Business Updates
AVTX

GlobeNewswire

9 months ago

Avalo Reports 2023 Financial Results and Provides Business Updates

Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million
AVTX

GlobeNewswire

9 months ago

Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million

NeuroSense’s (NASDAQ:NRSN) ALS Drug Candidate Shows Promise In Recent Phase 2b Trial; More Milestones To Come In 2024
AVTX

ACCESSWIRE

a year ago

NeuroSense’s (NASDAQ:NRSN) ALS Drug Candidate Shows Promise In Recent Phase 2b Trial; More Milestones To Come In 2024

Talphera Announces $26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Monetization and Equity Offering
AVTX

PR Newswire

a year ago

Talphera Announces $26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Monetization and Equity Offering

Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference
AVTX

GlobeNewswire

a year ago

Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference

Pasithea Therapeutics Announces Adjournment of Reconvened Meeting of Stockholders to December 29, 2023
AVTX

GlobeNewswire

a year ago

Pasithea Therapeutics Announces Adjournment of Reconvened Meeting of Stockholders to December 29, 2023

Avalo Therapeutics Announces 1-for-240 Reverse Stock Split
AVTX

GlobeNewswire

a year ago

Avalo Therapeutics Announces 1-for-240 Reverse Stock Split

Eco Wave Power Submits an Official Request to the SFSA to Receive an Authorization for the Repurchase of American Depositary Shares Representing Up to 10% of the Company's Shares
AVTX

PR Newswire

a year ago

Eco Wave Power Submits an Official Request to the SFSA to Receive an Authorization for the Repurchase of American Depositary Shares Representing Up to 10% of the Company's Shares

Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split
AVTX

GlobeNewswire

a year ago

Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split

17 Education & Technology Group Inc. Announces Third Quarter 2023 Unaudited Financial Results
AVTX

GlobeNewswire

a year ago

17 Education & Technology Group Inc. Announces Third Quarter 2023 Unaudited Financial Results

Bitcoin Depot Founder and CEO Brandon Mintz Honored in Forbes 30 Under 30 Finance List
AVTX

GlobeNewswire

a year ago

Bitcoin Depot Founder and CEO Brandon Mintz Honored in Forbes 30 Under 30 Finance List

Protara Therapeutics Announces Presentation of Additional Encouraging Data from Phase 1a ADVANCED-1 Trial of TARA-002 in NMIBC at the 24th Annual Meeting of the Society of Urologic Oncology
AVTX

GlobeNewswire

a year ago

Protara Therapeutics Announces Presentation of Additional Encouraging Data from Phase 1a ADVANCED-1 Trial of TARA-002 in NMIBC at the 24th Annual Meeting of the Society of Urologic Oncology

Accelerate Diagnostics (AXDX) Expands in In Vitro Diagnostics
AVTX

Zacks

a year ago

Accelerate Diagnostics (AXDX) Expands in In Vitro Diagnostics

bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post
AVTX

Business Wire

a year ago

bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post

PharmcoRx Pharmacy Launches Mark Cuban Cost Plus Drug Program Expanding Its In-Pharmacy Offerings
AVTX

PR Newswire

a year ago

PharmcoRx Pharmacy Launches Mark Cuban Cost Plus Drug Program Expanding Its In-Pharmacy Offerings

NanoString Comments on Delaware District Court Verdict
AVTX

Business Wire

a year ago

NanoString Comments on Delaware District Court Verdict

Here's What's Concerning About United-Guardian's (NASDAQ:UG) Returns On Capital
AVTX

Simply Wall St.

a year ago

Here's What's Concerning About United-Guardian's (NASDAQ:UG) Returns On Capital

Astrotech Reports First Quarter of Fiscal Year 2024 Financial Results
AVTX

GlobeNewswire

a year ago

Astrotech Reports First Quarter of Fiscal Year 2024 Financial Results

Longeveron Inc. (NASDAQ:LGVN) Q3 2023 Earnings Call Transcript
AVTX

Insider Monkey

a year ago

Longeveron Inc. (NASDAQ:LGVN) Q3 2023 Earnings Call Transcript

AVTX

Business Wire

a year ago

Mogo Reports Results for Q3 2023

Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates
AVTX

GlobeNewswire

a year ago

Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates

ShotSpotter, Inc. (NASDAQ:SSTI) Q3 2023 Earnings Call Transcript
AVTX

Insider Monkey

a year ago

ShotSpotter, Inc. (NASDAQ:SSTI) Q3 2023 Earnings Call Transcript

NetSol Technologies, Inc. (NASDAQ:NTWK) Q1 2024 Earnings Call Transcript
AVTX

Insider Monkey

a year ago

NetSol Technologies, Inc. (NASDAQ:NTWK) Q1 2024 Earnings Call Transcript

Paltalk, Inc. (NASDAQ:PALT) Q3 2023 Earnings Call Transcript
AVTX

Insider Monkey

a year ago

Paltalk, Inc. (NASDAQ:PALT) Q3 2023 Earnings Call Transcript

Kingstone Announces Estimated Third Quarter 2023 Catastrophe
AVTX

ACCESSWIRE

a year ago

Kingstone Announces Estimated Third Quarter 2023 Catastrophe

Seven Hills Realty Trust Announces Third Quarter 2023 Results
AVTX

Business Wire

a year ago

Seven Hills Realty Trust Announces Third Quarter 2023 Results

Share on Social Networks: